Pages that link to "Q43807982"
Jump to navigation
Jump to search
The following pages link to Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis: is a double dosage worthwhile? (Q43807982):
Displaying 15 items.
- Tauroursodeoxycholic acid preservation of photoreceptor structure and function in the rd10 mouse through postnatal day 30 (Q24649167) (← links)
- Use of ursodeoxycholic acid in patients with liver disease (Q34515643) (← links)
- Long-term effects of mid-dose ursodeoxycholic acid in primary biliary cirrhosis: a meta-analysis of randomized controlled trials (Q34550505) (← links)
- Current management of primary biliary cirrhosis and primary sclerosing cholangitis (Q35068031) (← links)
- Clinical observation of salvianolic acid B in treatment of liver fibrosis in chronic hepatitis B. (Q36308206) (← links)
- Natural history and management of primary biliary cirrhosis (Q37355843) (← links)
- Obeticholic acid and budesonide for the treatment of primary biliary cirrhosis (Q38175055) (← links)
- Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial (Q45163892) (← links)
- Early biochemical response to ursodeoxycholic acid predicts symptom development in patients with asymptomatic primary biliary cirrhosis (Q46049458) (← links)
- Early treatment with ursodeoxycholic acid for cholestasis in children on parenteral nutrition because of primary intestinal failure (Q47602094) (← links)
- Primary biliary cirrhosis (Q56428273) (← links)
- Guidelines for the management of primary biliary cirrhosis (Q56429943) (← links)
- Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases (Q90707736) (← links)
- Current and potential treatments for primary biliary cholangitis (Q91733388) (← links)
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Non-Bile Acid FXR Agonist Tropifexor (LJN452) in Healthy Volunteers (Q91861212) (← links)